Efficacy and safety of various Intravenous Methylprednisolone regimens in Moderate to Severe Thyroid Eye Disease: A systematic review

Efficacy and safety of various Intravenous Methylprednisolone regimens in Moderate to Severe Thyroid Eye Disease: A systematic review

This systematic review aims to assess the efficacy and safety of various intravenous methylprednisolone (IVMP) protocols for treating active moderate to severe thyroid eye disease (TED) and to find the most effective regimen with the least side effects. We conducted a comprehensive literature search...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ankita Aishwarya, Divanshi Shrivastava, Adarsh Kumar Singh, Rachna Agrawal
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2025-08-01
Series:	Indian Journal of Ophthalmology
Subjects:	graves orbitopathy graves’ ophthalmopathy intravenous methylprednisolone ivmp moderate to severe ted systematic review ted thyroid eye disease
Online Access:	https://journals.lww.com/10.4103/IJO.IJO_1808_24
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A Case Report on the Thyroid and Eye Connection: A Deep Dive into Evaluation and Treatment Strategies
by: Iqra Mushtaq, et al.
Published: (2025-06-01)

An Update on Medical Management of Thyroid Eye Disease with Insights on Teprotumumab
by: Smriti Dabas, et al.
Published: (2023-07-01)

A randomized controlled trial on the effect of hydroxychloroquine in mild Graves’ orbitopathy (GO-HCQ): study protocol
by: Chia-Hung Lin, et al.
Published: (2025-08-01)

Radioiodine Thyroid Ablation in Graves′ Hyperthyroidism: Merits and Pitfalls
by: J. Nwatsock, et al.
Published: (2012-01-01)

Low risk of thyroid eye disease (TED) following radioiodine (RAI) therapy in a multidisciplinary setting: a retrospective cohort study
by: John S. Vekinis, et al.
Published: (2025-08-01)

Safety, pharmacokinetics, and potential benefits of TSH-receptor-specific monoclonal autoantibody K1-70TM in Japanese Graves’ disease patients: results of a phase 1 trial
by: Jaeduk Yoshimura Noh, et al.
Published: (2025-08-01)

The role of hormonal imbalance in the development of autoimmune dacryoadenitis in endocrine orbitopathy
by: V. G. Likhvantseva, et al.
Published: (2014-07-01)

Can chimeric antigen receptors – based therapy bring a gleam of hope for thyroid-associated ophthalmopathy and other autoimmune diseases?
by: Zhou Weiyi, et al.
Published: (2025-04-01)

Rituximab in the treatment of Graves’ disease and endocrine ophthalmopathy. Opportunities and limitations
by: T. S. Panevin, et al.
Published: (2023-10-01)

Predictive demographic and clinical features for the development of dysthyroid optic neuropathy in a multi-ethnic TED population: a retrospective cohort study
by: Malik Moledina, et al.
Published: (2025-07-01)

Validation of Indonesian Graves’ Ophthalmopathy Quality of Life Questionnaire and Its Association with Clinical Activity and Severity of Graves’ Ophthalmopathy
by: Cecilia Anggraini, et al.
Published: (2025-01-01)

Teprotumumab and sensorineural hearing loss: a propensity score-matched retrospective cohort study
by: Maxim John Levy Barnett, et al.
Published: (2025-07-01)

Le langage minéral du territoire d'Elmet et la pensée du devenir dans Remains of Elmet de Ted Hughes
by: Sophie Elzière
Published: (2019-06-01)

SEARCH FOR TARGET TISSUE IN THE EYE ORBIT FOR AUTOIMMUNE AGGRESSION OF THYROID ANTIBODIES IN ENDOCRINE OPHTHALMOPATHY
by: V. G. Likhvantseva, et al.
Published: (2017-10-01)

“That Kids Are Reading Is More Important than What Kids Reading:”
by: Leilya Pitre
Published: (2025-05-01)

Sexual imagery and male-ego in Lawrence's “Tortoise Shout” and Ted Hughes' “Thought Fox”
by: Shaymaa Alsalihi, et al.
Published: (2025-07-01)

MMP14 as a central mediator of TGF-β1−induced extracellular matrix remodeling in graves’ orbitopathy
by: Xing Wang, et al.
Published: (2025-07-01)

Intravenous methylprednisolone versus oral prednisone for initial attacks of optic neuritis, A review of evidence
by: Teresita R. Castillo, MD, MHPEd
Published: (2005-06-01)

Graves' disease: A rare fate of Hashimoto's thyroiditis
by: Rahul Jadhav, et al.
Published: (2021-03-01)

Volumetric, topographic and structural changes of orbital apex soft tissues in optic neuropathy caused by edematous exophthalmos
by: O. Yu. Yatsenko
Published: (2014-07-01)

Long-term outcomes of graves disease in children treated with anti-thyroid drugs
by: Ya-Ting Chiang, et al.
Published: (2020-06-01)

Tyre Wear Measurements Using the Marker SBR in a Technical Retrofit Sustainable Drainage System (SuDS)
by: Johannes Wolfgang Neupert, et al.
Published: (2025-01-01)

The IL-4 Level among Patients with Autoimmune Thyroiditis in Al-Najaf Governorate, Iraq
by: Sarah Hasan Kadhum Al-Huchaimi, et al.
Published: (2025-04-01)

99mTc-pertechnetate cut-off to distinguish Graves\' disease from subacute thyroiditis
by: Amir Gholami, et al.
Published: (2025-06-01)

Methylprednisolone pulse therapy compared with intravenous dexamethasone for severe COVID-19 patients: a randomized clinical trial
by: Kaveh Haratian, et al.
Published: (2025-08-01)

Indicators of oxidative stress and tissue hypoxia in various phases of Graves’ orbitopathy activity
by: E. S. Taskina, et al.
Published: (2024-11-01)

The evolving therapeutic landscape of Graves’ disease in adults: present and future
by: Marius N Stan, et al.
Published: (2025-07-01)

A Rare Case Of Acute Pancreatitis Cause by Newly Diagnosed Graves’ Disease: A Successful Therapeutic Option
by: Azzaki Abubakar, et al.
Published: (2025-08-01)

Acute Flaccid Quadriparesis: An Uncommon Presentation of Common Disease
by: Vishal Chandra Sharma, et al.
Published: (2022-01-01)

Diagnostic and Follow-up Characteristics of Cases Presenting with Hyperthyroidism in Childhood
by: Yasemin Denkboy Öngen, et al.
Published: (2025-08-01)

Mural Painting of a Roman Lady from Viminacium: From Roman Matron to the Modern Icon
by: Jelena Anđelković Grašar, et al.
Published: (2015-05-01)

Clinical characteristics of thyroid eye disease and expression profile of peripheral blood immune cells
by: Hongli Lin, et al.
Published: (2025-08-01)

The incidence of hypothyroidism following the radioactive iodine treatment of graves' disease and the predictive factors influencing its development
by: Maha Husseni
Published: (2016-01-01)

Myasthenia gravis complicated by Graves’ disease: a case report
by: Larrey Kasereka Kamabu, et al.
Published: (2025-07-01)

The risk of thyroid diseases in lichen sclerosus patients: a systematic review and meta-analysis
by: Suvijak Untaaveesup, et al.
Published: (2025-12-01)

List of Abstracts
by: The Editor
Published: (2012-07-01)

List of Abstracts
by: The Editor
Published: (2012-07-01)

Structural Activity Relationship Analysis of New Diphenyl PFI-3 Analogues Targeting for the Treatment of Glioblastoma
by: Dong-Jin Hwang, et al.
Published: (2025-04-01)

Randomized clinical trial comparing removal followed by topical imiquimod versus removal followed by topical methylprednisolone in the treatment of keloids
by: Alexandre Spiandorello Ricciardi, et al.
Published: (2025-08-01)

Expression levels of T cell-related immune factors and their correlation with thyroid function in Graves’ disease with varied serum iodine status: insights into immunopathogenesis
by: Lilan Wang, et al.
Published: (2025-08-01)